Travere Therapeutics Inc（TVTX）价格预测TVTXTravere Therapeutics Inc

Alphio's TVTX stock price prediction model matches the current Travere Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $49.69 (-0.77%). The 1-week path is $48.17 (-3.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Travere Therapeutics Inc is currently a hold. The stock is priced at $49.60, which is significantly below the average analyst price target of $78 to $89, indicating potential upside. However, the RSI is at a low 19.437, suggesting the stock is oversold, which could lead to further price declines in the short term. The company reported a net loss of $34.79 million for Q2 2026, which is concerning, but it did achieve a revenue growth of 48% year-over-year, reaching $169 million. The main risk is the high debt to equity ratio of 2458.12%, indicating potential financial instability.

Travere Therapeutics Inc (TVTX) last closed at $50.08, losing -4.48%. These facts feed the 1-day and 1-week TVTX price prediction above.